Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SPX Technologies (SPXC) Assets (2016 - 2025)

SPX Technologies has reported Assets over the past 17 years, most recently at $3.6 billion for Q4 2025.

  • Quarterly results put Assets at $3.6 billion for Q4 2025, up 32.79% from a year ago — trailing twelve months through Dec 2025 was $3.6 billion (up 32.79% YoY), and the annual figure for FY2025 was $3.6 billion, up 32.79%.
  • Assets for Q4 2025 was $3.6 billion at SPX Technologies, up from $3.4 billion in the prior quarter.
  • Over the last five years, Assets for SPXC hit a ceiling of $3.6 billion in Q4 2025 and a floor of $1.9 billion in Q4 2022.
  • Median Assets over the past 5 years was $2.5 billion (2022), compared with a mean of $2.7 billion.
  • Biggest five-year swings in Assets: decreased 26.54% in 2022 and later soared 38.5% in 2024.
  • SPX Technologies' Assets stood at $2.6 billion in 2021, then decreased by 26.54% to $1.9 billion in 2022, then rose by 26.35% to $2.4 billion in 2023, then rose by 11.26% to $2.7 billion in 2024, then surged by 32.79% to $3.6 billion in 2025.
  • The last three reported values for Assets were $3.6 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.3 billion (Q2 2025) per Business Quant data.